Calcium pyrophosphate crystal deposition disease: diagnosis and treatment

Código QR

Calcium pyrophosphate crystal deposition disease: diagnosis and treatment

José Luis Rosales-Alexander,1 Jerónimo Balsalobre Aznar,1 César Magro-Checa2 1Rheumatology Department, Hospiten Ramblas, Santa Cruz de Tenerife, 2Rheumatology Department, San Cecilio University Hospital, Granada, Spain Abstract: Calcium pyrophosphate dihydrate crys...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rosales-Alexander JL, Balsalobre Aznar J, Magro-Checa C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/98dc04b5e3894e8aa9f25ced14ab1154
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Multilevel calcium pyrophosphate dihydrate deposition in cervical ligamentum flavum: clinical characteristics and imaging features
por: Yueh-Hsiu Lu, et al.
Publicado: (2021)

Update on the diagnosis and management of Behçet’s disease
por: Rokutanda R, et al.
Publicado: (2014)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis EM, et al.
Publicado: (2014)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009)

Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data
por: Gabriela Schmajuk, et al.
Publicado: (2021)

Current options for the treatment of Paget&rsquo;s disease of the bone
por: Daniela Merlotti, et al.
Publicado: (2009)

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
por: Fabrizio Cantini, et al.
Publicado: (2009)

Patient and clinician experiences and opinions of the use of a novel home use medical device in the treatment of peripheral vascular disease - a qualitative study
por: Charlotte E. Sedgwick, et al.
Publicado: (2021)

The epidemiology and treatment of gout
por: McGill NW
Publicado: (2011)

Therapeutic apheresis in autoimmune diseases
por: Bambauer R, et al.
Publicado: (2013)

Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009)

Treatment of systemic-onset juvenile arthritis with canakinumab
por: Peitz J, et al.
Publicado: (2015)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Scott DL, et al.
Publicado: (2011)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami M, et al.
Publicado: (2012)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca G, et al.
Publicado: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
por: Michael G Feely
Publicado: (2010)

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
por: Jill M Recla
Publicado: (2010)

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
por: Ali Gur, et al.
Publicado: (2009)

Retrospective analysis of treatment modalities in diabetic muscle infarction
por: Onyenemezu I, et al.
Publicado: (2014)

Rheumatoid arthritis-associated interstitial lung disease
por: Brown KK, et al.
Publicado: (2012)

New developments in the treatment of osteoarthritis – focus on biologic agents
por: Torrero JI, et al.
Publicado: (2015)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
por: Montepaone M, et al.
Publicado: (2014)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Augustine JM, et al.
Publicado: (2012)

No increased risk of Alzheimer’s disease among people with immune-mediated inflammatory diseases: findings from a longitudinal cohort study of U.S. older adults
por: Michael J. Booth, et al.
Publicado: (2021)

Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin- associated periodic syndromes
por: Bachove I, et al.
Publicado: (2014)

Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome
por: Pierre Quartier
Publicado: (2011)

A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control
por: Taylor SD, et al.
Publicado: (2013)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Masahiko Mihara, et al.
Publicado: (2011)

Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseases
por: Perez Alamino R, et al.
Publicado: (2012)

Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study
por: Franz Thiele, et al.
Publicado: (2021)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
por: Michaël Doumen, et al.
Publicado: (2021)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Athanasios-Dimitrios Bakasis, et al.
Publicado: (2021)

Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature
por: Alisa Carman Gotte
Publicado: (2009)

Update on the therapy of adult-onset Still’s disease with a focus on IL-1-inhibition: a systematic review
por: Claudia Kedor, et al.
Publicado: (2021)

A Rare Case of Fatal Hemorrhagic Stroke in a Young Female with Early Mixed Connective Tissue Disease
por: James R. Agapoff IV
Publicado: (2021)

Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study
Publicado: (2021)

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
por: Roy Fleischmann
Publicado: (2009)

Acquired Factor VIII Deficiency Presenting as Gross Hematuria in a Hispanic, Pregnant Patient with Previously Undiagnosed Connective Tissue Disease
por: Christine Loftis, et al.
Publicado: (2021)

Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis &ndash; a systematic evaluation of the literature
por: Tran TN, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension In Systemic Sclerosis: Challenges In Diagnosis, Screening And Treatment
por: Saygin D, et al.
Publicado: (2019)